Abstract
The effect of once-daily atenolol, sustained-release oxprenolol (a new formulation of oxprenolol presented as a compressed tablet in a waxed matrix), and long-acting propranolol (a new formulation presented as spheriods in a capsule) was studied in a double-blind crossover trial in 23 carefully selected hypertensive outpatients. After a run-in period with matching placebo each patient received atenolol (100 mg/day), sustained-release oxprenolol (160 mg/day), long-acting propranolol (160 mg/day), and placebo according to a randomised sequence. After four weeks' treatment with sustained-release oxprenolol blood pressure in the two to four hours before the next dose was not significantly lower than after placebo. The effectiveness of atenolol and of the new formulation of propranolol in reducing blood pressure was confirmed. These results suggest that the present formulation of sustained-release oxprenolol should be reconsidered.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bobik A., Jennings G. L., Korner P. I., Ashley P., Jackman G. Absorption and excretion of rapid and slow release oxprenolol and their effects on heart rate and blood pressure during exercise. Br J Clin Pharmacol. 1979 Jun;7(6):545–549. doi: 10.1111/j.1365-2125.1979.tb04640.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jeffers T. A., Webster J., Reid B., Petrie J. C., Barker N. P. Atenolol and metoprolol in mild hypertension. Br Med J. 1978 Nov 4;2(6147):1269–1269. doi: 10.1136/bmj.2.6147.1269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones D. H., Daniel J., Hamilton C. A., Reid J. L. Plasma noradrenaline concentration in essential hypertension during long-term beta-adrenoceptor blockade with oxprenolol. Br J Clin Pharmacol. 1980 Jan;9(1):27–31. doi: 10.1111/j.1365-2125.1980.tb04792.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Petrie J. C., Galloway D. B., Webster J., Simpson W. T., Lewis J. A. Atenolol and bendrofluazide in hypertension. Br Med J. 1975 Oct 18;4(5989):133–135. doi: 10.1136/bmj.4.5989.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waal-Manning H. J., Spears G. F. Experience with a slow-release formulation of oxprenolol. N Z Med J. 1978 Apr 12;87(609):245–246. [PubMed] [Google Scholar]